Yüklüyor......
Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
BACKGROUND: Administration of Hydroxychloroquine and Azithromycin in patients with coronavirus disease 2019 (COVID-19) prolongs QTc corrected interval (QTc). The effect and safety of Lopinavir/Ritonavir in combination with these therapies have seldom been studied. OBJECTIVES: Our aim was to evaluate...
Kaydedildi:
| Yayımlandı: | J Electrocardiol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7698653/ https://ncbi.nlm.nih.gov/pubmed/33307378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jelectrocard.2020.11.012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|